Targeting blood vessels to improve cancer immunotherapy – Science Daily
|
Targeting blood vessels to improve cancer immunotherapy
Science Daily Cancer immunotherapy aims to enhance or restore the ability of the patient’s immune system — namely T cells — to recognize and attack cancer. But tumors use several strategies to fight back immune attacks, making immunotherapy efficacious only in a … |
Times of India |
‘No proof that stem cell therapy can cure autism’
Times of India Whereas stem cell therapy is in research stage, its effectiveness is strongly doubted, even its practice is banned in many countries and if practised, it is done in labs and under strict regulations. In India at present there is no particular body or … |
Times of India |
‘No proof that stem cell therapy can cure autism’
Times of India Whereas stem cell therapy is in research stage, its effectiveness is strongly doubted, even its practice is banned in many countries and if practised, it is done in labs and under strict regulations. In India at present there is no particular body or … |
Newsmax |
University of California Files Appeal Over CRISPR Patents
Newsmax The University of California is appealing a U.S. patent ruling over the gene-editing technology known as CRISPR that favored the Broad Institute, a research … UC Files Appeal For CRISPR Patent Ruling To Reinstate …University Herald CRISPR Patent Battle: The Fight For Control Of Important Gene …Counsel & Heal |
Northglen News |
Sixth annual event in aid of stem cell donations
Northglen News The NPO’s mission is to educate and register blood stem cell donors to give hope of life to patients suffering from life-threatening chronic blood disorders like leukaemia. Funds raised from the breakfast will help The Sunflower Fund to cover the … |
|
VIDEO: Speaker reviews pros, cons of combining targeted therapy, immunotherapy for melanoma
Healio NEW YORK — Jason J. Luke, MD, FACP, assistant professor of medicine at University of Chicago, spoke at HemOnc Today Melanoma and Cutaneous Malignancies about the use of targeted therapy in combination with immunotherapy for the treatment of … |